image: Higher Mediterranean diet adherence is generally associated with a lower overall cancer risk. Evidence is more consistent for colorectal and gastric cancers than for other cancer types. Potential mechanisms involve inflammation, oxidative stress, metabolism, gut microbiota, and epigenetics. More studies in Asian and other non-Mediterranean populations are needed to inform cancer prevention.
Credit: Zhao J.-E. and Li W.-Q. (2026). Mediterranean diet and cancer risk: Current understanding and epidemiological evidence. The Innovation Nutrition 1(3), 100044.
Among the levers people can pull to lower their cancer risk, diet is the most daily — and the most disputed. Few dietary patterns have attracted more attention than the Mediterranean diet: abundant vegetables, fruits, legumes, whole grains, nuts, fish, and olive oil, with little red or processed meat. A narrative review published in The Innovation Nutrition weighs the epidemiological and mechanistic evidence behind its reputation, and finds a pattern that is encouraging but uneven.
The broad picture is one of inverse association. Across cohort studies and meta-analyses, higher adherence to the Mediterranean diet generally tracks with lower overall cancer risk. The signal is most consistent for colorectal and gastric cancers — plausibly, the authors note, because these tumors sit closest to the diet's main influence pathways: chronic inflammation, oxidative stress, metabolic dysregulation, gut microbiota composition, and epigenetic regulation. Individual components may contribute independently: unsaturated fatty acids, polyphenols, and dietary fiber each have proposed anti-carcinogenic roles. For other cancer sites, including prostate cancer, the evidence remains inconsistent.
The review is careful about what this evidence cannot yet say. Exposure definitions vary substantially between studies — there is no single standardized score for "Mediterraneanness" — and self-reported dietary data carry well-known measurement bias. Cancer type heterogeneity and regional differences in what people actually eat further complicate comparisons. Most fundamentally, the predominant study designs are observational, which limits causal inference: people who eat Mediterranean-style diets differ from others in many ways beyond the plate.
Geography is another boundary. The evidence base is built largely on European and American populations, whose dietary baselines, lifestyle contexts, and cancer spectra differ from those of Asia and other non-Mediterranean regions. Whether the same protective associations hold there — and what an adapted dietary pattern should look like — remains to be tested. The authors single this out as a research priority of direct relevance to cancer prevention in Asia.
Their roadmap is concrete: standardize Mediterranean diet assessment instruments; prioritize high-quality prospective cohort and interventional studies that can support causal inference; and apply multi-omics approaches to pin down which biological mechanisms — inflammatory, metabolic, microbial, or epigenetic — carry the strongest causal weight.
None of this diminishes the diet's broader appeal: the same pattern is already associated with cardiovascular and metabolic benefits, and the mechanistic plausibility for cancer is coherent. But the review's message to readers and researchers alike is that "associated with lower risk" is not yet "proven to prevent cancer" — and that the next round of evidence should come from better instruments, stronger designs, and populations far from the Mediterranean shore.
###
Zhao J.-E. and Li W.-Q. (2026). Mediterranean diet and cancer risk: Current understanding and epidemiological evidence. The Innovation Nutrition 1(3), 100044. https://doi.org/10.59717/j.xinn-nutri.2026.100044
Method of Research
Systematic review
Subject of Research
People
Article Title
Mediterranean diet and cancer risk: Current understanding and epidemiological evidence
Article Publication Date
24-Oct-2026
COI Statement
The authors declare no competing interests.